Hacker News Reader

What about the edge cases? If I understood you correctly, the poorest developed countries dictate the pricing.

Depends on if it is profitable to sell them drugs in that world.

If it isn't profitable, those countries either mostly do without or violate trade agreements (ignoring patents and the like).